Copy For Citation
AKAY A., ÇAPA KAYA G., Kose S., ERESEN YAZICIOĞLU Ç., Erkuran H. O., ALŞEN GÜNEY S., ...More
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol.86, pp.294-300, 2018 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
86
-
Publication Date:
2018
-
Doi Number:
10.1016/j.pnpbp.2018.04.008
-
Journal Name:
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.294-300
-
Keywords:
ADHD, DAT1 gene, [Tc-(99m)] TRODAT-1 SPECT, OROS-methylphenidate, DEFICIT HYPERACTIVITY DISORDER, DOPAMINE-TRANSPORTER GENE, ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, TC-99M-TRODAT-1 SPECT, PARKINSONS-DISEASE, CHILDREN, ASSOCIATION, ADULTS, PSYCHOSTIMULANTS, AVAILABILITY
-
Dokuz Eylül University Affiliated:
Yes
Abstract
Aim: To examine theeffects on the brain of 2-month treatment withamethylphenidate extended-release formulation (OROS-MPH) using [Tc-(99m)] TRODAT-1SPECT in a sample of treatment-naive adolescents with Attention Deficit/Hyperactivity Disorder (ADHD). In addition, to assess whether risk alleles (homozygosity for 10-repeat allele at the DAT1 gene were associated with alterations in striatal DAT availability.